CEACAM5 and cancer: We further noted an upregulation in the serum levels of carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP), which are commonly used clinical cancer markers, following S. flexneri C.11 treatment for 6 weeks, with a more significant difference at 14 weeks (Figure 3(H)).